HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating for Replimune Group, maintaining a price target of $17. Analyst Robert Burns continues to support the stock, indicating confidence in its potential.
September 16, 2024 | 10:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Replimune Group, maintaining a price target of $17. Analyst Robert Burns continues to support the stock, indicating confidence in its potential.
The reiteration of a Buy rating and maintenance of a $17 price target by HC Wainwright & Co. suggests positive sentiment and confidence in Replimune Group's future performance. This is likely to have a positive short-term impact on the stock price as investors may view this as a strong endorsement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100